- Report
- November 2026
- 174 Pages
Global
From €5493EUR$5,850USD£4,582GBP
- Report
- November 2026
- 184 Pages
Global
From €5493EUR$5,850USD£4,582GBP
- Report
- November 2026
- 266 Pages
Global
From €5493EUR$5,850USD£4,582GBP
- Report
- November 2026
- 242 Pages
Global
From €5493EUR$5,850USD£4,582GBP
- Report
- November 2026
- 103 Pages
Global
From €5493EUR$5,850USD£4,582GBP
- Report
- November 2026
- 306 Pages
Global
From €5493EUR$5,850USD£4,582GBP
- Report
- November 2026
- 170 Pages
Global
From €5493EUR$5,850USD£4,582GBP
- Report
- November 2026
- 380 Pages
Global
From €5493EUR$5,850USD£4,582GBP
- Report
- November 2026
- 160 Pages
Global
From €5493EUR$5,850USD£4,582GBP
- Report
- November 2026
- 148 Pages
Global
From €5493EUR$5,850USD£4,582GBP
- Report
- November 2026
- 383 Pages
Global
From €5493EUR$5,850USD£4,582GBP
- Report
- November 2026
- 286 Pages
Global
From €5493EUR$5,850USD£4,582GBP
- Report
- November 2026
- 236 Pages
Global
From €5493EUR$5,850USD£4,582GBP
- Report
- November 2026
- 231 Pages
Global
From €5493EUR$5,850USD£4,582GBP
- Report
- November 2026
- 182 Pages
Global
From €5493EUR$5,850USD£4,582GBP
- Report
- November 2026
- 178 Pages
Global
From €5493EUR$5,850USD£4,582GBP
- Report
- November 2026
- 193 Pages
Global
From €5493EUR$5,850USD£4,582GBP
- Report
- November 2026
- 485 Pages
Global
From €5493EUR$5,850USD£4,582GBP
- Report
- November 2026
- 218 Pages
Global
From €5493EUR$5,850USD£4,582GBP
- Report
- November 2026
- 194 Pages
Global
From €5493EUR$5,850USD£4,582GBP

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more